Aplaket tab

Manufacturer

Rotta

Distributor

Antah Pharma

Contents

Ticlopidine HCl

MIMS Class

Anticoagulants, Antithrombotics & Fibrinolytics

Indications

Secondary prevention of cerebral & cardiovascular occlusive ischaemia in patients w/ thrombotic risk. Prevention of aorta-coronary bypass graft occlusion, in extracorporeal circulation, in haemodialysis.

Dosage

1-2 tab daily.

Contraindication

Leucopenia, thrombocytopenia, agranulocytosis, bleeding diatheses, haemostatic disorders. Active pathological bleeding (such as bleeding GI ulcer, bleeding esophageal varices). Acute haemorrhagic cerebrovascular strokes. Severe hepatopathy. Pregnancy, lactation.

Precautions

Every 15 days for the 1st 3 mth of treatment, perform blood cell counting. Treatment should be immediately w/drawn when pharyngitis, ulcers of the buccal mucosa, angina, fever, bleeding or hematomas occur.

Adverse Reactions

Leucopenia, thrombocytopenia, GI discomfort, increase of transaminases & rarely, cholestatic jaundice.

Drug Interaction

NSAIDs, anticoagulants, potentially myelotoxic drugs.

Packing/Presentation

Form Packing/Price Photo

tablet 250mg x 30's (WM-RM61.35)

Pregnancy Category

B